epoprostenol 1.5 MG Injection
- RxCUI
- 562502
- RxNorm name
- epoprostenol 1.5 MG Injection
- Display name
- epoprostenol 1.5 MG Injection
- Full name
- epoprostenol 1.5 MG Injection
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:24
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Epoprostenol | EPOPROSTENOL | Gland Pharma Limited | 47f64fcd-cbf7-457a-9548-661fb10ff7e0 | 2026-01-06 | Warnings, Adverse reactions | 562502 |
| epoprostenol | EPOPROSTENOL | Sun Pharmaceutical Industries, Inc. | db57e498-db20-45e8-8298-b0cf0811d270 | 2025-04-23 | Warnings, Adverse reactions | 562502 |
| Veletri | EPOPROSTENOL | Actelion Pharmaceuticals US, Inc. | df502787-46ec-4dd1-a2c0-be90f6d95a5d | 2022-11-28 | Warnings, Adverse reactions | 562502 |
| EPOPROSTENOL | EPOPROSTENOL | Mylan Institutional LLC | 2a163b77-9e01-4516-b19c-f5a12ce48560 | 2022-05-15 | Warnings, Adverse reactions | 562502 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| df502787-46ec-4dd1-a2c0-be90f6d95a5d | epoprostenol 1.5 MG Injection [PSN] · epoprostenol 1.5 MG Injection [SCD] · epoprostenol 1.5 MG (as epoprostenol sodium) Injection [SY] | 3 | 15 | These highlights do not include all the information needed to use VELETRI safely and effectively. See full prescribing information for VELETRI. VELETRI ® (epoprostenol) for injection, for intravenous use Initial U.S. Approval: 1995 | 20221128 |
| db57e498-db20-45e8-8298-b0cf0811d270 | epoprostenol 1.5 MG Injection [PSN] · epoprostenol 1.5 MG Injection [SCD] · epoprostenol 1.5 MG (as epoprostenol sodium) Injection [SY] | 3 | 6 | These highlights do not include all the information needed to use EPOPROSTENOL FOR INJECTION safely and effectively. See full prescribing information for EPOPROSTENOL FOR INJECTION. EPOPROSTENOL for injection, for intravenous use Initial U.S. Approval: 1995 | 20250423 |
| 47f64fcd-cbf7-457a-9548-661fb10ff7e0 | epoprostenol 1.5 MG Injection [PSN] · epoprostenol 1.5 MG Injection [SCD] · epoprostenol 1.5 MG (as epoprostenol sodium) Injection [SY] | 3 | 5 | These highlights do not include all the information needed to use EPOPROSTENOL FOR INJECTION safely and effectively. See full prescribing information for EPOPROSTENOL FOR INJECTION. EPOPROSTENOL for injection, for intravenous use Initial U.S. Approval: 1995 | 20260106 |
| 2a163b77-9e01-4516-b19c-f5a12ce48560 | epoprostenol 1.5 MG Injection [PSN] · epoprostenol 1.5 MG Injection [SCD] · epoprostenol 1.5 MG (as epoprostenol sodium) Injection [SY] | 3 | 1 | These highlights do not include all the information needed to use EPOPROSTENOL FOR INJECTION safely and effectively. See full prescribing information for EPOPROSTENOL FOR INJECTION . EPOPROSTENOL for injection, for intravenous use Initial U.S. Approval: 1995 | 20220515 |